Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis

Clin Exp Dermatol. 2016 Jun;41(4):433-4. doi: 10.1111/ced.12770. Epub 2015 Nov 18.

Authors

G Haebich¹, A Mughal², N Tofazzal³

Affiliations

¹ Department of Dermatology, Singleton Hospital Swansea, Sketty Lane, Swansea, UK. [email protected].
² Department of Dermatology, Singleton Hospital Swansea, Sketty Lane, Swansea, UK.
³ Department of Cellular Pathology, Singleton Hospital Swansea, Sketty Lane, Swansea, UK.

PMID: 26577239
DOI: 10.1111/ced.12770

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Ankle / pathology
Female
Fingolimod Hydrochloride / adverse effects*
Humans
Melanoma / chemically induced*
Melanoma / diagnosis
Melanoma / surgery
Melanoma, Cutaneous Malignant
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Skin Neoplasms / chemically induced*
Skin Neoplasms / diagnosis
Skin Neoplasms / surgery

Substances

Fingolimod Hydrochloride